Job title: Researcher
Stefan Dengl is a Princpal Scientist in the Discovery Department of Large Molecule Research (LMR) within Roche Pharma Research and Early Development (pRED). Stefan received his PhD from the Ludwig-Maximilians University in Munich and did his postdoc at Roche on antibody stability and antibody-peptide coupling technologies. After his postdoc he worked as a scientist in the LMR Biostructure and Molecular Design unit until he took on the role of a labhead in HTP screening. One of his main interests is high-throughput generation and screening of complex antibody formats.